02/08/2023 - Managing Security Fatigue in the Laboratory Cybersecurity plays a more prominent role in today’s laboratories. Digitalization, remote work, and cloud applications make labs more connected and vulnerable to security breaches. Strong password policies and multi-factor authentication (MFA) improve security, though at a price. Security practices force laboratory workers to enter log-in credentials several times an hour, interrupting their workflows throughout the day. The resulting security fatigue frustrates people and leads to behaviors that can undermine security. [Read More]
02/08/2023 - Autoscribe Showcases Updated LIMS Technology at PITTCON At PITTCON 2023, visitors to the Autoscribe Informatics booth will see the key developments introduced to our flagship Matrix Gemini LIMS since the last PITTCON. The world’s most configurable Laboratory Information Management System (LIMS) has been further enhanced with a completely new web-based user interface as well as other significant changes and improvements. [Read More]
02/08/2023 - Global Battle to Rule Microchip Manufacturing COVID-19 impacted the supply of diagnostic testing needs like specimen tubes, personal protective equipment, and reagents. While demand for these supplies remains high, clinical diagnostic labs and healthcare testing facilities are not the only businesses impeded by supply shortages in the wake of the pandemic. Nearly every piece of electronic equipment used in the world relies on semiconductors (also referred to as integrated circuits or microchips), from cell phones and microwaves to pacemakers and automobiles. A global battle is being waged to boost the manufacturing of microchips and profit from the demand from nearly every market segment. [Read More]
02/08/2023 - Digital Transformation: A Unified Platform Approach For Data Intelligence for Scientific Enterprises Last June, the L7 Team attended Future Labs Live in Basel. Listen to Vasu Rangadass, Ph.D., L7 Informatics’ President and Chief Executive Officer, as he talks about digital transformation and the benefits of a unified platform approach for data intelligence for scientific enterprises. [Read More]
02/08/2023 - Enhancing the scientific lab experience Part 2: The data-centric environment This two-part blog series explores how to use LIMS to enhance the overall scientific experience. In our last blog, we focused on how flexible interaction with LIMS can improve the lab-centric environment . This time, we delve into how data-centric elements play a role. One of the main benefits of embracing digital transformation in the laboratory is better management, analysis, and tracking of data, contributing to the overall scientific experience. [Read More]
02/08/2023 - Key Considerations When Evaluating Pharmacovigilance System Providers (Part 2) Your safety program will be impacted by the system and provider you choose for years to come. Although system functionality frequently predominates in selection criteria, we have learned to consider key attributes of each candidate system vendor as early in the selection process as possible before selecting the best fit. [Read More]
02/08/2023 - A Quick Look at How Instrument Data is Captured in Logilab ELN In pretty much all laboratories, data capture from different types of instruments plays a vital role in their operations in terms of quality and compliance with requirements, standards and regulations. Traditionally, lab personnel recorded instrument data manually. But as the number of instruments used started to increase, and the volume of instrument data generated started to exponentially increase, human errors arising in the process of manual recording became inevitable. [Read More]
02/08/2023 - Astrix to Sponsor Lab of the Future 2023 in Boston The Lab of the Future Congress USA is back in Boston for 9-10 March 2023. Following the sell-out 2022 event, we have moved to the larger Renaissance Boston Waterfront to support the growth of the Congress. Join us and hundreds of life science research leaders for the most innovative and best attended congress on the future of biopharma R&D. [Read More] |